...ALK/ROS1 inhibitor, is highly effective in ALK-positive non-small-cell lung cancer (NSCLC), particularly for intracrania...
...ALK positivity, and Archer-based molecular testing identified a KLC1-ALK fusion (KLC1 exon 3-ALK exon 20). These finding...
...ALK, BRAF, MET, HER2, ROS1, NTRK, and NRG1. Data were collected from the Institute of Pathology at Carmel Medical Center...
...ALK, FGFR1/2/3, or ROS1 alterations (mutations or fusions) were detected, despite the technical capability of the assay ...
...ALK, Chalk5, and the GS3/GW families, which control starch composition, gelatinization temperature, chalkiness, and grai...
...ALK immunoreactivity in CD163-positive histiocytes and has been shown to respond favorably to ALK inhibitors. ALK-positi...
...ALK-oncogene+ NSCLC, potentially through M2-TAM accumulation and aberrant angiogenesis.CONCLUSIONOur study delineates th...
...ALK1 (paranuclear dot pattern), and ALK D5F3; HHV8 was negative. FISH confirmed ALK gene rearrangement, and targeted seq...
...ALK and PHOX2B, as well as somatic amplification of MYCN. The epigenetic regulator EZH2, a histone methyltransferase of ...
...ALK-TKIs) have demonstrated superior efficacy compared with chemotherapy in ALK-positive non-small cell lung cancer (NSC...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269